Objective： The aim of our study was to investigate the effect of Cinobufacini injection on the proliferat（on and apoptosis of human hepatocarcinoma HepG-2 cells. Methods： Cells proliferation was assessed by MTT ass...Objective： The aim of our study was to investigate the effect of Cinobufacini injection on the proliferat（on and apoptosis of human hepatocarcinoma HepG-2 cells. Methods： Cells proliferation was assessed by MTT assay, cells morphologic was observed by the inverted microscopy, Annexin V/PI stain was used to detect the apoptosis and necrosis of the tumor ceils. The expression of TOPOI mRNA and TOPO Ⅱ mRNAwere examined by RT-PCR. Results： Cinobufacini injection significantly inhibited HepG-2 cells proliferation in dose- and time-dependent ways. After Cinobufacini injection intervention, HepG-2 cells showed typical morphological changes： cells changed from polygon into round, chromatin looseness and karyolysis were observed. The percentages of apoptosis were 88.49%, 76.02%, 61.73% corresponding to the 48 h interference of 0.42 μg/mL, 0.21 μg/mL, 0.105 μg/mL Cinobufacini injection, perspectively. RT-PCR assay showed that Cinobufacini injection down-regulated TOPOI and TOPO Ⅱ expression at mRNA level. Conclusion： Cinobufacini can inhibit human hepatocarcinoma HepG-2 cells growth and induce tumor cells apoptosis, the mechanism of which might partly relate to the down-regulation of TOPOI mRNA and TOPO Ⅰ mRNA induced by Cinobufacini injection.展开更多
目的合成一系列新型结构6-芳基茚并异喹啉酮衍生物,并考察目标化合物对DNA拓扑异构酶Ⅰ(TopoⅠ)的抑制活性及其体外抗肿瘤活性。方法以茚和间氯苯甲酸为原料,分别合成高酞酸和4-甲氧基高酞酸;高酞酸通过脱水反应、与亚胺加成反应制得中...目的合成一系列新型结构6-芳基茚并异喹啉酮衍生物,并考察目标化合物对DNA拓扑异构酶Ⅰ(TopoⅠ)的抑制活性及其体外抗肿瘤活性。方法以茚和间氯苯甲酸为原料,分别合成高酞酸和4-甲氧基高酞酸;高酞酸通过脱水反应、与亚胺加成反应制得中间体6-芳基茚并异喹啉酮;该中间体与各种氨基取代的氯代物反应得到目标化合物。采用TopoGEN公司的Topoisomerase Ⅰ drug screning kit来测试目标化合物对TopoⅠ的抑制活性;选取人乳腺癌细胞(MCF-7)、非小细胞肺癌细胞(NIH-H460)和人神经胶质瘤细胞(U251)对目标化合物进行体外抗肿瘤活性筛选。结果与结论共合成了17个未见文献报道的新化合物,其结构均经MS(EI)、1H-NMR确证。体外活性筛选结果表明:目标化合物对TopoⅠ表现出良好的抑制作用,且对3种肿瘤细胞表现出较好的抗增殖活性。展开更多
文摘Objective： The aim of our study was to investigate the effect of Cinobufacini injection on the proliferat（on and apoptosis of human hepatocarcinoma HepG-2 cells. Methods： Cells proliferation was assessed by MTT assay, cells morphologic was observed by the inverted microscopy, Annexin V/PI stain was used to detect the apoptosis and necrosis of the tumor ceils. The expression of TOPOI mRNA and TOPO Ⅱ mRNAwere examined by RT-PCR. Results： Cinobufacini injection significantly inhibited HepG-2 cells proliferation in dose- and time-dependent ways. After Cinobufacini injection intervention, HepG-2 cells showed typical morphological changes： cells changed from polygon into round, chromatin looseness and karyolysis were observed. The percentages of apoptosis were 88.49%, 76.02%, 61.73% corresponding to the 48 h interference of 0.42 μg/mL, 0.21 μg/mL, 0.105 μg/mL Cinobufacini injection, perspectively. RT-PCR assay showed that Cinobufacini injection down-regulated TOPOI and TOPO Ⅱ expression at mRNA level. Conclusion： Cinobufacini can inhibit human hepatocarcinoma HepG-2 cells growth and induce tumor cells apoptosis, the mechanism of which might partly relate to the down-regulation of TOPOI mRNA and TOPO Ⅰ mRNA induced by Cinobufacini injection.
文摘目的合成一系列新型结构6-芳基茚并异喹啉酮衍生物,并考察目标化合物对DNA拓扑异构酶Ⅰ(TopoⅠ)的抑制活性及其体外抗肿瘤活性。方法以茚和间氯苯甲酸为原料,分别合成高酞酸和4-甲氧基高酞酸;高酞酸通过脱水反应、与亚胺加成反应制得中间体6-芳基茚并异喹啉酮;该中间体与各种氨基取代的氯代物反应得到目标化合物。采用TopoGEN公司的Topoisomerase Ⅰ drug screning kit来测试目标化合物对TopoⅠ的抑制活性;选取人乳腺癌细胞(MCF-7)、非小细胞肺癌细胞(NIH-H460)和人神经胶质瘤细胞(U251)对目标化合物进行体外抗肿瘤活性筛选。结果与结论共合成了17个未见文献报道的新化合物,其结构均经MS(EI)、1H-NMR确证。体外活性筛选结果表明:目标化合物对TopoⅠ表现出良好的抑制作用,且对3种肿瘤细胞表现出较好的抗增殖活性。
